http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#head http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#assertion http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#assertion http://bio2rdf.org/drugbank:DB00541 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB00622 http://bio2rdf.org/drugbank:DB00622 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB00622 http://bio2rdf.org/drugbank_resource:DB00541_DB00622 http://purl.org/dc/terms/identifier drugbank_resource:DB00541_DB00622 http://bio2rdf.org/drugbank_resource:DB00541_DB00622 http://purl.org/dc/terms/title DDI between Vincristine and Nicardipine - Nicardipine, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nicardipine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00541_DB00622 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00541_DB00622 http://www.w3.org/2000/01/rdf-schema#label DDI between Vincristine and Nicardipine - Nicardipine, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nicardipine is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB00622] http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#signature.MCwCFEbbD-1n0HkR http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#signature.MCwCFEbbD-1n0HkR http://purl.org/nanopub/x/hasSignature MCwCFEbbD+1n0HkROXETjwV5RzFWDwg+AhRGO2HNG/ZWBEFv1Eooqejks5Y3vA== http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#signature.MCwCFEbbD-1n0HkR http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://purl.org/dc/terms/created 2018-03-30T11:12:33.219+02:00 http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k#signature.MCwCFEbbD-1n0HkR http://bio2rdf.org/drugbank_resource:DB00541_DB00622_nanopub.RA4Ho9NL5vhPymZlrfeoAHBomXcedlMExy9mubx2ve01k http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234